CRISPR
$115.749876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$115.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$4.64 (-3.85%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell CRISPR and other stocks, options, and ETFs commission-free!
About CRSP
CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA.
CEO
Samarth Kulkarni
Employees
410
Headquarters
Zug, Zug
Founded
2014
Market Cap
8.82B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.24M
High Today
$119.37
Low Today
$114.32
Open Price
$119.28
Volume
1.07M
52 Week High
$220.20
52 Week Low
$42.83
Analyst Ratings
55%
of 20 ratings
Buy
55%
Hold
35%
Sell
10%
CRSP Earnings
-$1.50
-$0.20
$1.10
$2.40
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Apr 27, After Hours